Literature DB >> 28799131

Pulmonary vascular disease in a failed Fontan patient with Down's syndrome.

Masaya Aoki1, Keiichi Hirono2, Tomonori Higuma3, Yoko Suzuki4, Kazuhiko Nakayama4, Akio Yamashita3, Kazuaki Fukahara3, Fukiko Ichida2, Noriaki Emoto4, Naoki Yoshimura3.   

Abstract

It is well known that Down's syndrome is a strong risk factor for mortality after Fontan operations. We performed two lung biopsies in a Down's syndrome patient who underwent staged Fontan operations. The pathological findings revealed severe pulmonary arterial hypertrophy and a quantitative real-time polymerase chain reaction revealed the overexpression of endothelin and a decline in the eNOS level at the Fontan operation. Although the preoperative hemodynamic studies revealed that all of the criteria for Fontan had been fulfilled, the patient died of acute cardiac insufficiency, 35 days after the Fontan operation.

Entities:  

Keywords:  Down’s syndrome; Endothelial nitric oxide synthase; Endothelin system; Fontan circulation

Mesh:

Substances:

Year:  2017        PMID: 28799131     DOI: 10.1007/s11748-017-0809-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  10 in total

Review 1.  Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome.

Authors:  Tsutomu Saji
Journal:  Pediatr Int       Date:  2014-06       Impact factor: 1.524

2.  Quantitative analysis of pulmonary vascular disease in complete transposition of the great arteries.

Authors:  S Yamaki; F Tezuka
Journal:  Circulation       Date:  1976-11       Impact factor: 29.690

3.  Mortality after total cavopulmonary connection in children with the down syndrome.

Authors:  Monesha Gupta-Malhotra; Virgil E V Larson; Ronald M Rosengart; Hongfei Guo; James H Moller
Journal:  Am J Cardiol       Date:  2010-03-15       Impact factor: 2.778

4.  Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients.

Authors:  Hidekazu Ishida; Shigetoyo Kogaki; Hiroaki Ichimori; Jun Narita; Nobutoshi Nawa; Takayoshi Ueno; Kunihiko Takahashi; Futoshi Kayatani; Hidehumi Kishimoto; Masahiro Nakayama; Yoshiki Sawa; Maurice Beghetti; Keiichi Ozono
Journal:  Int J Cardiol       Date:  2011-02-26       Impact factor: 4.164

5.  Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome.

Authors:  Michele D'Alto; Emanuele Romeo; Paola Argiento; Antonello D'Andrea; Berardo Sarubbi; Anna Correra; Giancarlo Scognamiglio; Silvia Papa; Eduardo Bossone; Raffaele Calabrò; Carmine D Vizza; Maria G Russo
Journal:  Int J Cardiol       Date:  2011-07-28       Impact factor: 4.164

6.  Hemodynamics and arteriovenous malformations in cavopulmonary anastomosis: the case for residual antegrade pulsatile flow.

Authors:  Roland Henaine; Mathieu Vergnat; Olaf Mercier; Alain Serraf; Vincent De Montpreville; Jean Ninet; Emile A Bacha
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-13       Impact factor: 5.209

7.  Outcome of univentricular repair in patients with Down syndrome.

Authors:  Takeshi Furukawa; In-Sam Park; Tadahiro Yoshikawa; Tomomi Nishimura; Yukihiro Takahashic; Makoto Ando; Naoki Wada
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-21       Impact factor: 5.209

8.  Single ventricle repair in children with Down's syndrome.

Authors:  Naoki Wada; Yukihiro Takahashi; Makoto Ando; In-Sam Park; Takashi Sasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-03-14

9.  Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation.

Authors:  Roland Henaine; Mathieu Vergnat; Emile A Bacha; Bruno Baudet; Virginie Lambert; Emre Belli; Alain Serraf
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-06       Impact factor: 5.209

10.  Reevaluation of histomorphometric analysis of lung tissue in decision making for better patient selection for fontan-type operations.

Authors:  Katsuhide Maeda; Shigeo Yamaki; Hideaki Kado; Toshihide Asou; Arata Murakami; Shinichi Takamoto
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

  10 in total
  1 in total

Review 1.  Pulmonary Hypertension in the Population with Down Syndrome.

Authors:  Douglas S Bush; D Dunbar Ivy
Journal:  Cardiol Ther       Date:  2022-01-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.